Clinical Trial: A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Advanced Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase 1/1b Study to Evaluate the Safety and Tolerability of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies
Brief Summary:
The primary purpose of this study is to assess the safety and tolerability of AB801 in participants with advanced malignancies, and to determine a recommended AB801 dose for expansion.
Read more